Devchand Paul

Multicenter Phase II Study of Lapatinib in Patients with Brain Metastases from HER2-Positive Breast Cancer

Nancy U. Lin, Véronique Dièras, Devchand Paul et al. · Clinical Cancer Research · 2009 · 663 citations · Full text

Medicine, Oncology, Breast Oncology +15

Randomized Trial of Denosumab in Patients Receiving Adjuvant Aromatase Inhibitors for Nonmetastatic Breast Cancer

Georgiana K. Ellis, Henry G. Bone, Rowan T. Chlebowski et al. · Journal of Clinical Oncology · 2008 · 483 citations

Medicine, Oncology, Pharmacology +17

Anthracyclines in Early Breast Cancer: The ABC Trials—USOR 06-090, NSABP B-46-I/USOR 07132, and NSABP B-49 (NRG Oncology)

Joanne L. Blum, Patrick J. Flynn, Greg Yothers et al. · Journal of Clinical Oncology · 2017 · 288 citations · Full text

Medicine, Oncology, Pharmacology +16

Adjuvant docetaxel and cyclophosphamide plus trastuzumab in patients with HER2-amplified early stage breast cancer: a single-group, open-label, phase 2 study

Stephen E. Jones, Rufus Collea, Devchand Paul et al. · The Lancet Oncology · 2013 · 135 citations

Medicine, Oncology, Pharmacology +14

Sunitinib Plus Paclitaxel Versus Bevacizumab Plus Paclitaxel for First-Line Treatment of Patients With Advanced Breast Cancer: A Phase III, Randomized, Open-Label Trial

Nicholas J. Robert, Mansoor N. Saleh, Devchand Paul et al. · Clinical Breast Cancer · 2011 · 118 citations · Full text

Medicine, Oncology, Pharmacology +8